From Oral Antipsychotic to INVEGA SUSTENNA® – General Overview

Consistent with the INVEGA SUSTENNA® Prescribing Information:

• There are no systematically collected data to specifically address switching patients with schizoaffective disorder from other antipsychotics to INVEGA SUSTENNA®, or concerning concomitant administration with other antipsychotics.
• For patients who have never taken oral paliperidone or oral or injectable risperidone, tolerability should be established with oral paliperidone or oral risperidone prior to initiating treatment with INVEGA SUSTENNA®.
• Previous oral antipsychotics can be gradually discontinued at the time of initiation of treatment with INVEGA SUSTENNA®. Recommended initiation of INVEGA SUSTENNA® is with a dose of 234 mg followed by 156 mg one week later, both administered in the deltoid muscle.

For illustrative displays of this dosing scenario, please click the link(s) below.

Switching from Oral Antipsychotics for Schizoaffective Disorder